Methods
GHD
GHD
This was a cross-sectional, observational study that quantitatively assessed physicians’ experience with once-weekly somatrogon and once-daily rhGH in pediatric patients with GHD, via an online survey.English-speaking physicians who were clinical investigators in the phase III trial (NCT02968004) sponsored by OPKO Health were eligible for inclusion if they had treated at least two children with GHD with once-weekly somatrogon as part of the phase III trial, either during the randomization phase or the open-label extension phase of the study and had prior experience with using once-daily rhGH. Up to 50 eligible physicians were planned to be enrolled in the study.